92 related articles for article (PubMed ID: 12938206)
1. Prevalence of anti-human respiratory syncytial virus antibodies over three consecutive years in a healthy adult population.
Chala SR; García-Barreno B; Melero JA; Palomo C
J Med Virol; 2003 Oct; 71(2):298-304. PubMed ID: 12938206
[TBL] [Abstract][Full Text] [Related]
2. Serum antibody response to respiratory syncytial virus F and N proteins in two populations at high risk of infection: children and elderly.
Sastre P; Cusi MG; Manoha C; Schildgen O; Ruiz T; Vela C; Rueda P
J Virol Methods; 2010 Sep; 168(1-2):170-6. PubMed ID: 20488207
[TBL] [Abstract][Full Text] [Related]
3. Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities.
Sastre P; Melero JA; García-Barreno B; Palomo C
Vaccine; 2004 Dec; 23(4):435-43. PubMed ID: 15530691
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the seroprevalence of human metapneumovirus and human respiratory syncytial virus.
Ebihara T; Endo R; Kikuta H; Ishiguro N; Ishiko H; Kobayashi K
J Med Virol; 2004 Feb; 72(2):304-6. PubMed ID: 14695674
[TBL] [Abstract][Full Text] [Related]
5. Detection of human respiratory syncytial virus genotype specific antibody responses in infants.
McGill A; Greensill J; Marsh R; Craft AW; Toms GL
J Med Virol; 2004 Nov; 74(3):492-8. PubMed ID: 15368511
[TBL] [Abstract][Full Text] [Related]
6. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
[TBL] [Abstract][Full Text] [Related]
7. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
Marsh R; Connor A; Gias E; Toms GL
J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
[TBL] [Abstract][Full Text] [Related]
8. Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons.
Zlateva KT; Vijgen L; Dekeersmaeker N; Naranjo C; Van Ranst M
J Clin Microbiol; 2007 Sep; 45(9):3022-30. PubMed ID: 17609323
[TBL] [Abstract][Full Text] [Related]
9. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
10. Comparison of affinity chromatography and adsorption to vaccinia virus recombinant infected cells for depletion of antibodies directed against respiratory syncytial virus glycoproteins present in a human immunoglobulin preparation.
Sastre P; Melero JA; García-Barreno B; Palomo C
J Med Virol; 2005 Jun; 76(2):248-55. PubMed ID: 15834867
[TBL] [Abstract][Full Text] [Related]
11. Role of complement in neutralization of respiratory syncytial virus.
Yoder SM; Zhu Y; Ikizler MR; Wright PF
J Med Virol; 2004 Apr; 72(4):688-94. PubMed ID: 14981775
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains.
Palomo C; Cane PA; Melero JA
J Med Virol; 2000 Apr; 60(4):468-74. PubMed ID: 10686032
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
McGill A; Marsh R; Craft AW; Toms GL
J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze.
Stensballe LG; Ravn H; Kristensen K; Agerskov K; Meakins T; Aaby P; Simões EA
J Allergy Clin Immunol; 2009 Feb; 123(2):398-403. PubMed ID: 19101023
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of respiratory syncytial virus group B genotype BA-IV strains among children with acute respiratory tract infection in Kolkata, Eastern India.
Agrawal AS; Sarkar M; Ghosh S; Chawla-Sarkar M; Chakraborty N; Basak M; Naik TN
J Clin Virol; 2009 Aug; 45(4):358-61. PubMed ID: 19570709
[TBL] [Abstract][Full Text] [Related]
16. Experimental infection of humans with A2 respiratory syncytial virus.
Lee FE; Walsh EE; Falsey AR; Betts RF; Treanor JJ
Antiviral Res; 2004 Sep; 63(3):191-6. PubMed ID: 15451187
[TBL] [Abstract][Full Text] [Related]
17. Age related differences in humoral immune response to respiratory syncytial virus infection in adults.
Walsh EE; Falsey AR
J Med Virol; 2004 Jun; 73(2):295-9. PubMed ID: 15122807
[TBL] [Abstract][Full Text] [Related]
18. Liu-He-Tang inhibited plaque formation by human respiratory syncytial virus infection in cell lines of the human respiratory tract.
Chang JS; Wang KC; Shieh DE; Chiang LC
J Ethnopharmacol; 2011 Oct; 137(3):1149-55. PubMed ID: 21810459
[TBL] [Abstract][Full Text] [Related]
19. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
[TBL] [Abstract][Full Text] [Related]
20. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults.
Walsh EE; Falsey AR
J Infect Dis; 2004 Jul; 190(2):373-8. PubMed ID: 15216475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
